CannTrust Holdings Inc. (CTST)
(Delayed Data from NYSE)
$6.05 USD
+0.46 (8.23%)
Updated May 3, 2019 04:02 PM ET
After-Market: $6.08 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
CannTrust Holdings Inc. [CTST]
Reports for Purchase
Showing records 1 - 20 ( 63 total )
Company: CannTrust Holdings Inc.
Industry: Medical - Drugs
Company: CannTrust Holdings Inc.
Industry: Medical - Drugs
Company: CannTrust Holdings Inc.
Industry: Medical - Drugs
Consumer - Cannabis Industry Update: Canadian Cannabis One Year Later
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: CannTrust Holdings Inc.
Industry: Medical - Drugs
Company: CannTrust Holdings Inc.
Industry: Medical - Drugs
Destroying C$77M Worth of Plants, Inventory to Regain Compliance.
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: CannTrust Holdings Inc.
Industry: Medical - Drugs
Company: CannTrust Holdings Inc.
Industry: Medical - Drugs
Company: CannTrust Holdings Inc.
Industry: Medical - Drugs
Company: CannTrust Holdings Inc.
Industry: Medical - Drugs
Company: CannTrust Holdings Inc.
Industry: Medical - Drugs
Company: CannTrust Holdings Inc.
Industry: Medical - Drugs
Company: CannTrust Holdings Inc.
Industry: Medical - Drugs
Company: CannTrust Holdings Inc.
Industry: Medical - Drugs
Company: CannTrust Holdings Inc.
Industry: Medical - Drugs
Company: CannTrust Holdings Inc.
Industry: Medical - Drugs
Company: CannTrust Holdings Inc.
Industry: Medical - Drugs
Company: CannTrust Holdings Inc.
Industry: Medical - Drugs
Company: CannTrust Holdings Inc.
Industry: Medical - Drugs
Consumer - Cannabis: Industry Sentiment - Cannabis Investment Context
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S